切换至 "中华医学电子期刊资源库"

中华损伤与修复杂志(电子版) ›› 2023, Vol. 18 ›› Issue (01) : 59 -64. doi: 10.3877/cma.j.issn.1673-9450.2023.01.009

综述

瘢痕鳞状细胞癌的研究进展
张文涵1, 王成2,()   
  1. 1. 100191 北京大学医学部
    2. 100035 北京积水潭医院烧伤科
  • 收稿日期:2022-11-12 出版日期:2023-02-01
  • 通信作者: 王成
  • 基金资助:
    北京积水潭医院"学科骨干"计划专项经费资助项目(XKGG202114); 北京积水潭医院"自然基金培育计划"资助项目(ZR-202208)

Research progress in scar squamous cell carcinoma

Wenhan Zhang1, Cheng Wang2,()   

  1. 1. Peking University Health Science Center, Beijing 100191, China
    2. Department of Burn, Beijing Jishuitan Hospital, Beijing 100035, China
  • Received:2022-11-12 Published:2023-02-01
  • Corresponding author: Cheng Wang
引用本文:

张文涵, 王成. 瘢痕鳞状细胞癌的研究进展[J]. 中华损伤与修复杂志(电子版), 2023, 18(01): 59-64.

Wenhan Zhang, Cheng Wang. Research progress in scar squamous cell carcinoma[J]. Chinese Journal of Injury Repair and Wound Healing(Electronic Edition), 2023, 18(01): 59-64.

瘢痕鳞状细胞癌是瘢痕癌的一种常见的类型。在感染、紫外线照射等致癌因素环境下,瘢痕组织常发生癌变,尤以瘢痕鳞状细胞癌占比最高。烧伤瘢痕是瘢痕鳞状细胞癌最常见的恶性转移病灶,其发生也与手术及创伤病史、难愈合瘢痕病变及感染等因素相关。瘢痕恶性转化的发生率低且具有隐匿性,常导致诊断困难、延迟甚至漏诊,增加患者的晚期转移率,导致患者预后不良。因此,本文着重探讨了瘢痕鳞状细胞癌发生的流行情况、病因、发病机制、临床表现及病理表现,综述了针对不同类型病变现有的手术治疗与辅助疗法,为早期诊断和预防做准备,以期降低瘢痕鳞状细胞癌发生率、改善患者预后。

Scar squamous cell carcinoma is a common type of scar carcinoma. In the environment of infection, ultraviolet radiation and other carcinogenic factors, scar tissue often becomes cancerous, especially in scar squamous cell carcinoma. Scar squamous cell carcinoma is most common in malignant transformation of burn scars, and its occurrence is also related to surgical and trauma history, chronic ulcers, and infection. The incidence of malignant transformation of scar is low and occult, which often leads to difficulty in diagnosis, delay or even missed diagnosis, increases the late metastasis rate of patients, and leads to poor prognosis. Therefore, this article focuses on the prevalence, etiology, pathogenesis, clinical presentations and histopathology of scar squamous cell carcinoma, and reviews the existing surgical treatment and adjuvant therapy for different types of lesions, so as to prepare for early diagnosis and prevention, in order to reduce the incidence of scar squamous cell carcinoma and improve the prognosis of patients.

[1]
Guo BW, Pan T, Chen HB, et al. Clinicopathologic Characteristics and Prognosis Analysis of Marjolin′s Ulcer in 40 Cases[J]. Curr Med Sci, 2018, 38(6): 1038-1044.
[2]
张家平,江旭品. 瘢痕癌性溃疡诊断与治疗专家共识(2020年版)[J/CD]. 中华损伤与修复杂志(电子版), 2020, 15(4): 264-267.
[3]
Kanth AM, Heiman AJ, Nair L, et al. Current Trends in Management of Marjolin′s Ulcer: A Systematic Review[J]. J Burn Care Res, 2021, 42(2): 144-151.
[4]
Das KK, Chakaraborty A, Rahman A, et al. Incidences of malignancy in chronic burn scar ulcers: experience from Bangladesh[J]. Burns, 2015, 41(6): 1315-1321.
[5]
Kim JM, Su WP, Kurtin PJ, et al. Marjolin′s ulcer: immunohistochemical study of 17 cases and comparison with common squamous cell carcinoma and basal cell carcinoma[J]. J Cutan Pathol, 1992, 19(4): 278-285.
[6]
Oruç M, Kankaya Y, Sungur N, et al. Clinicopathological evaluation of Marjolin ulcers over two decades[J]. Kaohsiung J Med Sci, 2017, 33(7): 327-333.
[7]
Alvarez Rio A, Roca Mas JO, Navarro Sanchez D, et al. Aggressive Acute Marjolin′s Ulcer Arising in a Burn Scar[J]. Case Rep Dermatol Med, 2022, 2022: 8329050.
[8]
Chiriac AE, Betiu M, Brzezinski P, et al. Malignant Degeneration of Scars[J]. Cancer Manag Res, 2020, 12: 10297-10302.
[9]
Kawaguchi M, Kato H, Tomita H, et al. Magnetic Resonance Imaging Findings Differentiating Cutaneous Basal Cell Carcinoma from Squamous Cell Carcinoma in the Head and Neck Region[J]. Korean J Radiol, 2020, 21(3): 325-331.
[10]
Abdi MA, Yan M, Hanna TP. Systematic Review of Modern Case Series of Squamous Cell Cancer Arising in a Chronic Ulcer (Marjolin′s Ulcer) of the Skin[J]. JCO Glob Oncol, 2020, 6: 809-818.
[11]
Saaiq M, Ashraf B. Marjolin′s ulcers in the post-burned lesions and scars[J]. World J Clin Cases, 2014, 2(10): 507-514.
[12]
Copcu E. Marjolin′s ulcer: a preventable complication of burns?[J]. Plast Reconstr Surg, 2009, 124(1): 156e-164e.
[13]
Boykin JV, Eriksson E, Pittman RN. In vivo microcirculation of a scald burn and the progression of postburn dermal ischemia[J]. Plast Reconstr Surg, 1980, 66(2): 191-198.
[14]
Prasanna M, Mishra P, Thomas C. Delayed primary closure of the burn wounds[J]. Burns, 2004, 30(2): 169-175.
[15]
Kowal-Vern A, Criswell BK. Burn scar neoplasms: a literature review and statistical analysis[J]. Burns, 2005, 31(4): 403-413.
[16]
Zuo KJ, Tredget EE. Multiple Marjolin′s ulcers arising from irradiated post-burn hypertrophic scars: a case report[J]. Burns, 2014, 40(4): e21-25.
[17]
Eliassen A, Vandy F, McHugh J, et al. Marjolin′s ulcer in a patient with chronic venous stasis[J]. Ann Vasc Surg, 2013, 27(8): 1182.e5-8.
[18]
Smith J, Mello LF, Nogueira Neto NC, et al. Malignancy in chronic ulcers and scars of the leg (Marjolin′s ulcer): a study of 21 patients[J]. Skeletal Radiol, 2001, 30(6): 331-337.
[19]
Conlon C, Pupa L, Reece EM, et al. When Benign Becomes Cancer: Malignant Degeneration of Chronic Inflammation[J]. Semin Plast Surg, 2021, 35(3): 159-163.
[20]
秦国强,丁明华. MEBO联合NPWT、自体微粒皮种植技术在瘢痕性压疮治疗中的创新应用[C]//第15届全国烧伤创疡学术会议论文汇编,2018: 339-343.
[21]
Furtado C, Datta P, Zeitoun R. Radiological appearances of metastatic Marjolin ulcer in a chronic pressure sore: a case report and literature review[J]. Radiol Case Rep, 2022, 17(10): 3907-3910.
[22]
Allepot K, Curings P, Viard R, et al. Diagnostic pitfall: Early arising, multiple and recurrent Marjolin′s ulcer. About 8 patients (16 tumors) and literature review[J]. Ann Chir Plast Esthet, 2021, 66(2): 151-158.
[23]
Ghadiri SJ, Kloczko E, Flohr C. Topical treatments in the management of keloids and hypertrophic scars: a critically appraised topic[J]. Br J Dermatol, 2022, 187(6): 855-856.
[24]
Nielsen RM, Andersen F, Salskov-Iversen ML. Squamous cell carcinoma in ulcer after bacille Calmette-Guérin vaccination[J]. Ugeskr Laeger, 2014, 176(42): V01140059.
[25]
Kluger N, Dissard C. Basal cell carcinoma in a smallpox vaccination scar[J]. Presse Med, 2014, 43(3): 332-333.
[26]
Bazaliński D, Przybek-Mita J, Barańska B, et al. Marjolin′s ulcer in chronic wounds - review of available literature[J]. Contemp Oncol (Pozn), 2017, 21(3): 197-202.
[27]
Czarnecki D, Nicholson I, Tait B, et al. HLA DR4 is associated with the development of multiple basal cell carcinomas and malignant melanoma[J]. Dermatology, 1993, 187(1): 16-18.
[28]
Harland DL, Robinson WA, Franklin WA. Deletion of the p53 gene in a patient with aggressive burn scar carcinoma[J]. J Trauma, 1997, 42(1): 104-107.
[29]
Lee SH, Shin MS, Kim HS, et al. Somatic mutations of Fas (Apo-1/CD95) gene in cutaneous squamous cell carcinoma arising from a burn scar[J]. J Invest Dermatol, 2000, 114(1): 122-126.
[30]
Wang L, Hou S, Li J, et al. Circular RNA circ-LARP1B contributes to cutaneous squamous cell carcinoma progression by targeting microRNA-515-5p/TPX2 microtubule nucleation factor axis[J]. Bioengineered, 2022, 13(1): 1209-1223.
[31]
Chen J, Hou SF, Tang FJ, et al. HOTAIR/Sp1/miR-199a critically regulates cancer stemness and malignant progression of cutaneous squamous cell carcinoma[J]. Oncogene, 2022, 41(1): 99-111.
[32]
Sinha S, Su S, Workentine M, et al. Transcriptional Analysis Reveals Evidence of Chronically Impeded ECM Turnover and Epithelium-to-Mesenchyme Transition in Scar Tissue Giving Rise to Marjolin′s Ulcer[J]. J Burn Care Res, 2017, 38(1): e14-e22.
[33]
Foster DS, Jones RE, Ransom RC, et al. The evolving relationship of wound healing and tumor stroma[J]. JCI Insight, 2018, 3(18): e99911.
[34]
Lu P, Weaver VM, Werb Z. The extracellular matrix: a dynamic niche in cancer progression[J]. J Cell Biol, 2012, 196(4): 395-406.
[35]
Alhysoni KA, Bukhari SM, Hajjaj MF. Acute Marjolin′s Ulcer in a Postauricular Scar after Mastoidectomy[J]. Case Rep Otolaryngol, 2016, 2016: 2046954.
[36]
Burusapat C, Wanichjaroen N, Wongprakob N, et al. Characteristics of Marjolin′s Ulcers in 21st Century: A Retrospective Study, Systematic Review, and Surgical Guideline Recommendation[J]. J Burn Care Res, 2021, 42(2): 152-166.
[37]
Sadegh Fazeli M, Lebaschi AH, Hajirostam M, et al. Marjolin′s ulcer: clinical and pathologic features of 83 cases and review of literature[J]. Med J Islam Repub Iran, 2013, 27(4): 215-224.
[38]
牛大伟,韩志新,李振超,等. 31例烧伤后瘢痕癌患者的临床治疗分析[J]. 中国烧伤创疡杂志2021, 33(4): 291-295.
[39]
Pratt DV, Pelton RW, Patel BC, et al. Burn scar malignancies of the eyelids[J]. Ophthalmic Plast Reconstr Surg, 2000, 16(6): 432-437.
[40]
Tavares E, Martinho G, Dores JA, et al. Marjolin′s ulcer associated with ulceration and chronic osteomyelitis[J]. An Bras Dermatol, 2011, 86(2): 366-369.
[41]
Sánchez-García A, Alonso-Carpio M, Trapero A, et al. Atypical Presentation of a Marjolin Ulcer After a Burn: A Case Report[J]. Plast Surg Nurs, 2020, 40(4): 195-196.
[42]
Bozkurt M, Kapi E, Kuvat SV, et al. Current concepts in the management of Marjolin′s ulcers: outcomes from a standardized treatment protocol in 16 cases[J]. J Burn Care Res, 2010, 31(5): 776-780.
[43]
Shen R, Zhang J, Zhang F, et al. Clinical characteristics and therapeutic analysis of 51 patients with Marjolin′s ulcers[J]. Exp Ther Med, 2015, 10(4): 1364-1374.
[44]
Brantsch KD, Meisner C, Sch?nfisch B, et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study[J]. Lancet Oncol, 2008, 9(8): 713-720.
[45]
Motley R, Arron S. Mohs micrographic surgery for cutaneous squamous cell carcinoma[J]. Br J Dermatol, 2019, 181(2): 233-234.
[46]
Karasoy Yesilada A, Zeynep Sevim K, Özgur Sucu D, et al. Marjolin ulcer: clinical experience with 34 patients over 15 years[J]. J Cutan Med Surg, 2013, 17(6): 404-409.
[47]
Yoo JJ, Kim HS, Kim JH, et al. Clinical features and treatment outcomes of skin cancer arising from burn scar: a single-institution experience[J]. Tumori, 2014, 100(1): 26-30.
[48]
Pala M, Novakova P, Pechacova Z, et al. Long-term results of radio(chemo)therapy in metastatic carcinoma to cervical lymph nodes from an unknown primary. Adult Comorbidity Evaluation 27 score as a predictor of survival[J]. Strahlenther Onkol, 2023, 199(2): 149-159.
[49]
Marcus J, Glassberg E, Dimino-Emme L, et al. Photodynamic therapy for the treatment of squamous cell carcinoma using benzoporphyrin derivative[J]. J Dermatol Surg Oncol, 1994, 20(6): 375-382.
[50]
Shi L, Liu P, Wu J, et al. The effectiveness and safety of X-PDT for cutaneous squamous cell carcinoma and melanoma[J]. Nanomedicine (Lond), 2019, 14(15): 2027-2043.
[51]
Keyal U, Bhatta AK, Zhang G, et al. Present and future perspectives of photodynamic therapy for cutaneous squamous cell carcinoma[J]. J Am Acad Dermatol, 2019, 80(3): 765-773.
[52]
Keyal U, Luo Q, Bhatta AK, et al. Zinc pthalocyanine-loaded chitosan/mPEG-PLA nanoparticles-mediated photodynamic therapy for the treatment of cutaneous squamous cell carcinoma[J]. J Biophotonics, 2018, 11(11): e201800114.
[53]
Almeida Gonçalves JC. Advanced cancer of the extremities treated by cryosurgery[J]. G Ital Dermatol Venereol, 2011, 146(4): 249-255.
[54]
Lee CN, Pan SC, Lee JY, et al. Successful treatment of cutaneous squamous cell carcinoma with intralesional cryosurgery: Case report[J]. Medicine (Baltimore), 2016, 95(39): e4991.
[55]
Xu C, Zhuo Y, Liu Y, et al. Itraconazole Inhibits the Growth of Cutaneous Squamous Cell Carcinoma by Targeting HMGCS1/ACSL4 Axis[J]. Front Pharmacol, 2022, 13: 828983.
[56]
Zhang Z, Deng X. circ_0001821 Contributes to the Development of Cutaneous Squamous Cell Carcinoma by Regulating MicroRNA-148a-3p/EGFR Axis and Activating Phosphatidylinositol 3-Kinase/Akt Pathway[J]. Mol Cell Biol, 2022, 42(3): e0008921.
[57]
Liang D, Zhang Z. MicroRNA-27b-3p inhibits the proliferation and invasion of cutaneous squamous cell carcinoma by targeting EGFR and MMP-13[J]. Oncol Lett, 2021, 22(4): 729.
[1] 应康, 杨璨莹, 刘凤珍, 陈丽丽, 刘燕娜. 左心室心肌应变对无症状重度主动脉瓣狭窄患者的预后评估价值[J]. 中华医学超声杂志(电子版), 2023, 20(06): 581-587.
[2] 姚咏明. 如何精准评估烧伤脓毒症患者免疫状态[J]. 中华损伤与修复杂志(电子版), 2023, 18(06): 552-552.
[3] 李越洲, 张孔玺, 李小红, 商中华. 基于生物信息学分析胃癌中PUM的预后意义[J]. 中华普通外科学文献(电子版), 2023, 17(06): 426-432.
[4] 张俊, 罗再, 段茗玉, 裘正军, 黄陈. 胃癌预后预测模型的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(06): 456-461.
[5] 杨倩, 李翠芳, 张婉秋. 原发性肝癌自发性破裂出血急诊TACE术后的近远期预后及影响因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 33-36.
[6] 栗艳松, 冯会敏, 刘明超, 刘泽鹏, 姜秋霞. STIP1在三阴性乳腺癌组织中的表达及临床意义研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 52-56.
[7] 马伟强, 马斌林, 吴中语, 张莹. microRNA在三阴性乳腺癌进展中发挥的作用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 111-114.
[8] 江振剑, 蒋明, 黄大莉. TK1、Ki67蛋白在分化型甲状腺癌组织中的表达及预后价值研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 623-626.
[9] 晏晴艳, 雍晓梅, 罗洪, 杜敏. 成都地区老年转移性乳腺癌的预后及生存因素研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 636-638.
[10] 鲁鑫, 许佳怡, 刘洋, 杨琴, 鞠雯雯, 徐缨龙. 早期LC术与PTCD续贯LC术治疗急性胆囊炎对患者肝功能及预后的影响比较[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 648-650.
[11] 姜明, 罗锐, 龙成超. 闭孔疝的诊断与治疗:10年73例患者诊疗经验总结[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 706-710.
[12] 卢艳军, 马健, 白鹏宇, 郭凌宏, 刘海义, 江波, 白文启, 张毅勋. 纳米碳在腹腔镜直肠癌根治术中253组淋巴结清扫的临床效果[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 473-477.
[13] 李永胜, 孙家和, 郭书伟, 卢义康, 刘洪洲. 高龄结直肠癌患者根治术后短期并发症及其影响因素[J]. 中华临床医师杂志(电子版), 2023, 17(9): 962-967.
[14] 王军, 刘鲲鹏, 姚兰, 张华, 魏越, 索利斌, 陈骏, 苗成利, 罗成华. 腹膜后肿瘤切除术中大量输血患者的麻醉管理特点与分析[J]. 中华临床医师杂志(电子版), 2023, 17(08): 844-849.
[15] 索利斌, 刘鲲鹏, 姚兰, 张华, 魏越, 王军, 陈骏, 苗成利, 罗成华. 原发性腹膜后副神经节瘤切除术麻醉管理的特点和分析[J]. 中华临床医师杂志(电子版), 2023, 17(07): 771-776.
阅读次数
全文


摘要